Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Blood Rev. 2017 Jul 15;31(6):362–369. doi: 10.1016/j.blre.2017.07.002

Table 1.

Summary of reduced-intensity HSCT trials in AML.

Publication Type of study Number
of
patients		 Age
range
(years)		 Follow-up
(months)		 Incidence
of relapse
(%)		 NRM
(%)		 DFS
(%)		 OS
(%)
Sorror5 Retrospective 372 60–75 55 41 27 32 35
Farag6 Retrospective 94 60–70 36 32 36 32 37
Koreth52 Retrospective 158 60–71 34 54.6 10 35 46
Chevallier53 Retrospective 600 60–65 23.7 25 32.3 46.2 49.2
Devine22 Prospective 114 60–74 40 47 14 39 46
Niederwieser54 Prospective 132 60–74 96 40.5 28.7 32.5 35.5